68Ga-Somatostatine Analogs: Rare Diseases

  • Cristina NanniEmail author
  • Stefano Fanti


A 56-year-old male patient was diagnosed with a pancreatic mass at ultrasound and was therefore referred for a 68Ga-DOTA NOC PET/CT to assess the presence of somatostatin receptors (Fig. 74.1). The scan result was negative. The patient was subsequently operated on, and the final diagnosis was cystic serous adenocarcinoma of the pancreas.


Chronic Pancreatitis Neuroendocrine Tumor Carcinoid Tumor Cystic Tumor Pancreatic Pseudocyst 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Reading

  1. Fukasawa M, Maguchi H, Takahashi K, Katanuma A, Osanai M, Kurita A, Ichiya T, Tsuchiya T, Kin T (2010) Clinical features and natural history of serous cystic neoplasm of the pancreas. Pancreatology 10(6):695–701PubMedCrossRefGoogle Scholar

  1. Ketata S, Ketata H, Fakhfakh H, Sahnoun A, Bahloul A, Boudawara T, Mhiri MN (2006) Pure primary neuroendocrine tumor of the prostate: a rare entity. Clin Genitourin Cancer 5(1):82–84PubMedCrossRefGoogle Scholar

  1. Pezzilli R (2009) Etiology of chronic pancreatitis: has it changed in the last decade? World J Gastroenterol 15(38):4737–4740PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  1. 1.Dept. of Nuclear MedicineOspedale S. Orsola-MalpighiBolognaItaly
  2. 2.Policlinico S.Orsola-Malpighi Dipto. Medicina NucleareUniv. BolognaBolognaItaly

Personalised recommendations